1.
Breccia M, Alimena G. SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs. Mediterr J Hematol Infect Dis [Internet]. 2014Jan.2 [cited 2020Apr.4];6(1):e2014003. Available from: http://www.mjhid.org/index.php/mjhid/article/view/2014.003